In Case You Missed It
5 Things You Must Know Before the Market Opens
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Endo International plc
An FDA advisory committee has found that risks of Endo International's pain drug Opana ER now overshadow the drug's benefits.
We answer recent reader questions about three of the biotech stocks we regularly cover.
Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.
Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.